Machine Learning Model Enables Accelerated Enrollment Timelines in Parkinson's Disease Clinical Trials

Smaller control groups allow more patients to be assigned to the treatment arm, which may accelerate enrollment, particularly in trials where concerns about placebo assignment deter participation.